Health Industry Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.

Press releases published on July 24, 2026

Eric Marienthal, David Benoit and Niki Haris Headline 27th Annual Benefit Concert for High Hopes
Qué son los doshas y por qué son la clave del Ayurveda para comprender la salud de cada persona en Panamá
Narconon UK Celebrates the 60th Anniversary of its international Drug and Alcohol Rehabilitation Programme
NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026
Pelthos Therapeutics Announces 2026 Annual Meeting of Stockholders
Mdxhealth Announces Receipt of Nasdaq Notification Regarding  Minimum Market Value of Listed Securities Deficiency
Author James Mbela Releases 'Healing with Psychedelics & Shamanic Plant Medicines: A Practical Guide'
ColestZen Publishes Ingredient Facts for Its 18-Ingredient Supplement Formula: Serving Directions and Safety Information for 2026
SPECTRA PROVIDES STORAGE AND FULFILLMENT SERVICES FOR PEPTIDES
One Water Systems Highlights Final Weeks of July 2026 Water Filtration Savings Campaign
Sarcomatrix Therapeutics Opens Accredited Investor Round for Once-Daily Pill to Address Duchenne Across Genetic Mutation
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Maxim Hair Restoration Named Top US Hair Restoration Brand 2026, Reinforcing Its Position Among the Best Hair Restoration Clinics in America
Ireland Bans Electroshock Treatment on Minors: A Major Human Rights Advance, Citizens Commission on Human Rights International Says
IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026
Sienna Announces Confirmation of Morningstar DBRS Credit Rating
ThreeBestRated® Honouree Nez Erok of Zen Life Counselling on Helping Clients Find Growth, Connection, and Confidence
VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future Growth
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LifeMD to Report Second Quarter 2026 Financial Results on August 5

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Industry Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.